a CTMS for device trials needs to track signed investigator agreements, monitor sites against the investigational plan, manage deviations and their reporting clocks, check device accountability at every visit, and follow participants for months or years after the procedure. Cloudbyz CTMS is a Salesforce-native clinical trial management system that device sponsors can configure for this, on the same platform as Cloudbyz EDC, eTMF, CTFM and Safety & Pharmacovigilance. It suits MedTech companies of every size, from early-stage developers to global multinationals.
|
Requirement |
Source |
What the CTMS needs to track |
|---|---|---|
|
Signed investigator agreement before participation |
21 CFR 812.43 |
Agreement status before site activation |
|
Monitoring to secure compliance, and action on non-compliance |
21 CFR 812.46 |
Monitoring visits, findings, escalation |
|
Records of device receipt, use and disposition |
21 CFR 812.140 |
Device accountability checks at each visit |
|
Unanticipated adverse device effects reported within 10 working days |
21 CFR 812.150 |
Event dates and reporting deadlines |
|
Emergency deviations reported within 5 working days |
21 CFR 812.150 |
Deviation records with dates and clocks |
In the EU, clinical investigations of devices fall under the Medical Device Regulation (Regulation (EU) 2017/745), with its own requirements for sponsor oversight and safety reporting. If monitoring finds an investigator is not complying, FDA rules require the sponsor to secure compliance or stop device shipments and end the investigator's participation, so monitoring findings need a clear trail.
The Cloudbyz team can walk through a device study from site start-up to long-term follow-up. Book a demo or visit cloudbyz.com.